U
Magenta Therapeutics, Inc. MGTA
NASDAQ
Recommendation
--
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
--
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
There are no news to display.
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, August 3, 2023
Period Date
Friday, June 30, 2023
Next Filing
Beginning of November (est)
Price History
Loading...
Beta
7-Day Total Return
--
30-Day Total Return
--
60-Day Total Return
--
90-Day Total Return
--
Year to Date Total Return
--
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Market Cap
-- - --
Enterprise Value
--
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Phone Number
857 242 0170
Address
100 Technology Square
Cambridge, MA 02139
Country
Year Founded
Business Description
Sector
As of September 11, 2023, Magenta Therapeutics, Inc. was acquired by Dianthus Therapeutics, Inc., in a reverse merger transaction. Magenta Therapeutics, Inc., a biotechnology company focus on... more
Weiss Ratings